ARFEVI
ActiveSummary
ARFEVI has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €102,800 and a net result of €221,583. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 26% of 17112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency55▼-45
Growth58▼-20
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7,000 at 30 days acceptable
Liquidity tight (current ratio 1.42 against 22.09 in 2024; short-term debt: 69.1% and cash: 22.1% of total assets), and 69.8% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
30.2%
Return on assets
65.1%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 26-12-2025, 36 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
36 d early
2024
21 d early
2023
41 d early
2022
48 d early
2021
39 d early
2020
18 d early
2019
1 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 29 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 23 December (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-06-2026 close01-10-2026 today31-01-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€102,800▼ 67.3%
2024 · €314,838
Total assets
€340,295▲ 2.1%
2024 · €333,254
Net result
€221,583▲ 4.5%
2024 · €212,038
Working capital
€99,737▼ 67.9%
2024 · €311,019
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€262,508▲ 56.5%€286,453▲ 9.1%€279,978▼ 2.3%€284,644▲ 1.7%€296,511▲ 4.2%
Net result€201,517above the sector's middle half▲ 61.2%€237,762above the sector's middle half▲ 18.0%€214,377above the sector's middle half▼ 9.8%€212,038above the sector's middle half▼ 1.1%€221,583above the sector's middle half▲ 4.5%
Equity€514,632above the sector's middle half▲ 64.4%€20,460below the sector's middle half▼ 96.0%€234,837within the sector's middle half▲ 1,048%€314,838within the sector's middle half▲ 34.1%€102,800within the sector's middle half▼ 67.3%
Total assets€585,063within the sector's middle half▲ 58.9%€275,920within the sector's middle half▼ 52.8%€328,074within the sector's middle half▲ 18.9%€333,254within the sector's middle half▲ 1.6%€340,295within the sector's middle half▲ 2.1%
Debt€70,431▲ 28.1%€255,460▲ 263%€93,237▼ 63.5%€18,416▼ 80.2%€237,495▲ 1,190%
Working capital€498,174above the sector's middle half▲ 68.3%€7,538below the sector's middle half▼ 98.5%€226,123within the sector's middle half▲ 2,900%€311,019above the sector's middle half▲ 37.5%€99,737within the sector's middle half▼ 67.9%
Solvency88.0%above the sector's middle half▲ 2.9pp7.4%below the sector's middle half▼ 80.5pp71.6%within the sector's middle half▲ 64.2pp94.5%above the sector's middle half▲ 22.9pp30.2%within the sector's middle half▼ 64.3pp
Current ratio8.15above the sector's middle half▲ 1.661.03below the sector's middle half▼ 7.123.47within the sector's middle half▲ 2.4422.09above the sector's middle half▲ 18.621.42within the sector's middle half▼ 20.67
Return on assets (ROA)34.4%above the sector's middle half▲ 0.5pp86.2%above the sector's middle half▲ 51.7pp65.3%above the sector's middle half▼ 20.8pp63.6%above the sector's middle half▼ 1.7pp65.1%above the sector's middle half▲ 1.5pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 4% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €340,295
Fixed assets
€5,472 ▼ 26.9%
Current assets
€334,824 ▲ 2.8%
Equity and liabilities €340,295
Equity
€102,800 ▼ 67.3%
Debt
€237,495 ▲ 1,190%
Debt's share of the balance-sheet total rises from 5.5% to 69.8%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€298,527▲
2024 · €287,548
Cash flow
€223,599▲
2024 · €214,941
Debt to equity
2.31▲
2024 · 0.06
ROE
215.5%▲
2024 · 67.3%
Interest coverage
144.72▲
2024 · 103.70
Debt ≤ 1 year
€235,086▲
2024 · €14,747
Income taxes
€76,692▲
2024 · €74,323
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3,274 | €3,873 | €4,023 | €2,903 | €2,016 | ▼ 30.6% |
| Other operating charges640/8 | - | €112 | €150 | €500 | €528 | ▲ 5.6% |
| Non-recurring operating charges66A | - | - | - | - | €3,100 | - |
| Gross operating margin9900 | €265,893 | €290,439 | €284,151 | €288,047 | €302,154 | ▲ 4.9% |
| Operating profit (loss)9901 | €262,508 | €286,453 | €279,978 | €284,644 | €296,511 | ▲ 4.2% |
| Financial income75/76B | - | €26,970 | €3 | €4,490 | €3,827 | ▼ 14.8% |
| Recurring financial income75 | €570 | €26,970 | €3 | €4,490 | €3,827 | ▼ 14.8% |
| Financial charges65/66B | - | €768 | €354 | €2,773 | €2,063 | ▼ 25.6% |
| Recurring financial charges65 | €329 | €768 | €354 | €2,773 | €2,063 | ▼ 25.6% |
| Profit (loss) for the period before taxes9903 | €262,748 | €312,655 | €279,627 | €286,361 | €298,275 | ▲ 4.2% |
| Income taxes67/77 | €61,232 | €74,893 | €65,249 | €74,323 | €76,692 | ▲ 3.2% |
| Profit (loss) for the period9904 | €201,517 | €237,762 | €214,377 | €212,038 | €221,583 | ▲ 4.5% |
| Transfer to tax-exempt reserves689 | - | - | €84,200 | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €201,517 | €237,762 | €130,177 | €212,038 | €221,583 | ▲ 4.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €585,063 | €275,920 | €328,074 | €333,254 | €340,295 | ▲ 2.1% |
| Fixed assets21/28 | €17,188 | €14,414 | €10,391 | €7,488 | €5,472 | ▼ 26.9% |
| Tangible fixed assets22/27 | €17,188 | €14,414 | €10,391 | €7,488 | €5,472 | ▼ 26.9% |
| Land and buildings22 | - | €3,379 | €1,471 | €591 | €260 | ▼ 56.0% |
| Plant, machinery and equipment23 | - | €1,218 | €638 | €150 | - | - |
| Furniture and vehicles24 | - | €9,817 | €8,282 | €6,747 | €5,211 | ▼ 22.8% |
| Current assets29/58 | €567,875 | €261,506 | €317,683 | €325,766 | €334,824 | ▲ 2.8% |
| Amounts receivable within one year40/41 | €58,768 | €48,973 | €58,929 | €29,384 | €19,589 | ▼ 33.3% |
| Trade receivables40 | - | €48,973 | €39,179 | €29,384 | €19,589 | ▼ 33.3% |
| Other amounts receivable41 | - | - | €19,751 | - | - | - |
| Current investments50/53 | €74,216 | - | - | €187,287 | €137,647 | ▼ 26.5% |
| Cash at bank and in hand54/58 | €335,836 | €103,685 | €139,019 | €8,270 | €75,128 | ▲ 808% |
| Deferred charges and accrued income490/1 | - | €108,847 | €119,735 | €100,825 | €102,459 | ▲ 1.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €585,063 | €275,920 | €328,074 | €333,254 | €340,295 | ▲ 2.1% |
| Equity10/15 | €514,632 | €20,460 | €234,837 | €314,838 | €102,800 | ▼ 67.3% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €496,032 | €1,860 | €216,237 | €296,238 | €84,200 | ▼ 71.6% |
| Non-distributable reserves130/1 | - | €1,860 | - | - | - | - |
| Reserves not available under the articles1311 | - | €1,860 | - | - | - | - |
| Tax-exempt reserves132 | - | - | €84,200 | €84,200 | €84,200 | = |
| Distributable reserves133 | - | - | €132,037 | €212,038 | - | - |
| Amounts payable17/49 | €70,431 | €255,460 | €93,237 | €18,416 | €237,495 | ▲ 1,190% |
| Amounts payable within one year42/48 | €69,701 | €253,968 | €91,560 | €14,747 | €235,086 | ▲ 1,494% |
| Trade debts44 | €867 | €1,508 | €2,405 | €2,184 | €1,361 | ▼ 37.7% |
| Suppliers440/4 | - | €1,508 | €2,405 | €2,184 | €1,361 | ▼ 37.7% |
| Taxes, remuneration and social security45 | - | €10,033 | - | €4,220 | €2,101 | ▼ 50.2% |
| Taxes450/3 | - | €10,033 | - | €4,220 | €2,101 | ▼ 50.2% |
| Other amounts payable47/48 | - | €242,427 | €89,155 | €8,342 | €231,625 | ▲ 2,676% |
| Accrued charges and deferred income492/3 | - | €1,492 | €1,677 | €3,669 | €2,409 | ▼ 34.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €201,517 | €237,762 | €214,377 | €212,038 | €221,583 | ▲ 4.5% |
| + Depreciation and write-downs630 | €3,274 | €3,873 | €4,023 | €2,903 | €2,016 | ▼ 30.6% |
| Operating cash flow (approximation) | €204,791 | €241,635 | €218,400 | €214,941 | €223,599 | ▲ 4.0% |
| Investment in fixed assets (approximation) | - | -€1,099 | €0 | €0 | €0 | - |
| Change in cash | - | -€232,151 | €35,334 | -€130,749 | €66,859 | ▲ 151% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
26-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
10-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial
Liquidity times 6current ratio 22.09
Current ratio from 3.47 to 22.09; short-term debt falls from €91,560 to €14,747.
2023
21-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
30-06
Financial
Liquidity triplescurrent ratio 3.47
Current ratio from 1.03 to 3.47; short-term debt falls from €253,968 to €91,560.
30-06
Financial
Equity above €200,000Eq €234,837 ▲1,048%
5 profitable years in a row build equity to €234,837.
2022
14-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
30-06
Financial
Highest result since 2019net €237,762 ▲18%
Net result €237,762, the highest in the series.
2021
23-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
30-06
Financial
Equity above €500,000Eq €514,632 ▲64.4%
3 profitable years in a row build equity to €514,632.
13-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial
Weakest financial yearnet €124,984 ▼27%
Net result drops to €124,984, the lowest in the series; recovery starts the following year.
Show earlier events
30-06
Financial
Liquidity triplescurrent ratio 6.49
Current ratio from 2.52 to 6.49; short-term debt falls from €109,909 to €53,928.
30-06
Financial
Equity above €200,000Eq €313,115 ▲71.4%
2 profitable years in a row build equity to €313,115.
30-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 2 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Kortrijk · 1 establishment unit since 2018
Ground area
6.1 ha
Building footprint
2.0 ha
Volume, LiDAR
1,661 m³
2 parcels, Flanders · tallest building 9.4 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
ARFEVI
since 20182.281.614.796
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 33306B0309/00A002 | Flanders | 5.9 ha | 1 · 2.0 ha | - |
| 34026A0471/00H002 | Flanders | 2,667 m² | 1 · 412 m² | 9.4 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.
Recognitions · licences · registrations
Legal Entity Identifier
875500IF6CG9S6QLGI23
Similar companies · same sector, comparable size
PHYSIOMEGA
BE 0741.949.436
Mettet · Eq €102,816
CETHIURO
BE 0478.556.329
Gerpinnes · Eq €102,843
CARDIOLOGIE AZ DELTA
BE 0545.787.128
Roeselare · Eq €102,705
De Praktijk KH
BE 0696.841.169
Knokke-Heist · Eq €102,903
N-EURO
BE 1023.099.778
Wezembeek-Oppem · Eq €102,570
Of 16,625 companies in this sector we hold annual accounts for 7,989. 6,363 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded29-10-2018
Fiscal year end30-06
Activities, NACEBEL 2025
86220Specialist medical practice
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID
0208:0712661770
Also
9925:BE0712661770
Registered
24-11-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.